Important: This site is no longer maintained! For the latest updates, please visit

Long-term sequelae to foodborne disease

R.M. McDowell1 & M.D. McElvaine2

1Policy and Program Development.
Animal and Plant Health inspection Service,
United States Department of Agriculture,
4700 River Road,
Riverdale, MD 20737,
United States of America
2Office of Risk Assessment and Cost-Benefit Analysis,
United States Department of Agriculture,
1400 Independence Avenue SW,
Room 5248-S,
Washington, DC 20250,
United States of America
(Corresponding author)


Most of the concern about foodborne disease has been focused on the immediate effects of acute infection. Recent information has shown that many of these foodborne infections also have long-term sequelae with serious health effects and a significant economic impact. To increase the awareness of animal health professionals to these sequelae, the authors discuss two groups of sequelae which are strongly associated with preceding infection (reactive arthritides, including Reiter's syndrome, and the Guillain-Barré syndrome) as well as the possible association between Crohn's disease and Mycobacterium paratuberculosis. The discussion includes a description of the disease syndromes along with epidemiological and economic information. More reliable epidemiological and economic data on chronic sequelae to foodborne disease will be needed for future evaluation of the cost-effectiveness of mitigation strategies to reduce the occurrence of foodborne pathogens.


Chronic disease sequelae - Crohn's disease - Foodborne disease - Guillain-Barré syndrome - Public health - Reactive arthritis.


Foodborne diseases exact a considerable toll on public health. In the United States of America (USA) alone, the best estimates suggest between 6 million and 33 million cases of foodbome disease and up to 9,000 foodbome disease-related deaths annually8. The most noticeable manifestation of foodbome disease is acute illness characterised by symptoms which may include diarrhoea, cramps, fever and vomiting. For the elderly, the very young, and other groups of immuno-compromised people, the risk of death from foodbome disease is significantly higher than for healthy individuals. In addition to acute illness and death, less well-known but significant impacts of foodbome diseases are long-term sequelae to infections created by pathogens frequently acquired through exposure to contaminated foods. Although the data on long-term complications to foodbome diseases are not collected and disseminated systematically, evidence suggests that the economic effects of these complications may exceed the costs of acute illness2.

The authors seek to increase the awareness of animal health professionals to the variety, health significance and economic impacts of long-term sequelae to foodbome diseases. With increasing awareness and understanding of these problems, the effects and possible mitigation approaches can be incorporated into the emerging practice of quantitative risk analysis in food safety. The discussion is focused on bacterial pathogens which are spread from food animals to man. To illustrate the diversity and significance of these complications, three of the better-known examples are discussed, as follows:

  1. reactive arthritides from enteric pathogens
  2. Guillain-Barré syndrome associated with Campylobacter jejuni exposure
  3. Crohn's disease and the possible association with Mycobacterium paratuberculosis in cattle.

For the sake of brevity, foodbome parasites and viruses are not included in the discussion, although these too can create significant complications8. In particular, the effects of congenital toxoplasmosis infection are particularly serious and generate a high rate of impairment in exposed individuals, with attendant lifelong economic costs13.

Reactive arthritis from enteric pathogens

The discomfort and inconvenience of diarrhoea and vomiting associated with acute infection by organisms such as Salmonella (in particular S. Enteritidis and S. Typhimurium), Campylobacter jejuni, Shigella sp. and Yersinia are well-known; the frequency and seriousness of the long-term complications associated with these pathogens are not as well documented. Infections from these organisms appear to give rise to a number of chronic joint diseases which include reactive arthritis, Reiter's syndrome and ankylosing spondylitis (18). In these sterile, reactive arthritides, the triggering organisms are not found in the affected joints and no rheumatoid factor is present, but elevated antibody levels to these organisms are present in the host16.

Symptoms commonly begin approximately 7 to 30 days after an intestinal illness. The knee is often infected along with other peripheral joints. Reiter's syndrome, considered a special case of reactive arthritis, typically includes three symptoms: asymmetric arthritis (joints on opposite limbs are affected) in knees and ankles, a non-specific urethritis and conjunctivitis. The duration of symptoms varies considerably, but in most individuals, symptoms subside in less than six months. However, some individuals may take in excess of one year to recover fully, and a significant portion of affected persons suffer persistent or relapsing illnesses. In addition to environmental factors, genetic factors play a significant role in the development of the reactive arthritides following exposure to a triggering organism. Approximately 6%-10% of white Americans, 2%-3% of African Americans and 1% of Japanese people carry the gene for susceptibility18. A recent review of foodbome diseases reported that approximately 2%-3% of all exposed individuals develop one of the reactive arthritides8. However, approximately 20% of exposed susceptible individuals will develop one of the reactive arthritides, with Reiter's syndrome occurring ten times less frequently than reactive arthritis2.

Detailed epidemiological investigations of several foodbome disease outbreaks suggest that these rates may understate the true number of cases and the associated economic impact of reactive arthritides due to foodbome disease. An outbreak of Salmonella Enteritidis among physicians found that 108 of 113 (95.6%) exposed patients were developing salmonellosis; of the 108 ill people, 17(15.7%) subsequently developed one of the reactive arthritides10. In another outbreak involving 116 people who became ill due to Salmonella Typhimurium, 16.4% of those ill developed reactive arthritis and 9.4% developed conjunctivitis15. Nearly 40% of those with reactive arthritis had symptoms which persisted for over one year. The attack rate for reactive arthritis among exposed persons in these outbreaks is 7 to 8 times higher than the generally reported rate (2%-3%). Unfortunately no recent comprehensive analysis of the economic impact of these diseases is available in the literature; however, the effects are discussed by Archer and Kvenberg1 and Archer and Youn2. Smith et al. estimated that 100,000 to 200,000 cases of reactive arthritis arise from foodbome infections each year it the USA18.

Guillain-Barré syndrome and Campylobacter jejuni infection

Campylobacter jejuni is commensal in the intestinal tracts of birds; thus, as a foodbome disease pathogen, infection is most often associated with poultry17. This pathogen is the most common source of foodbome illness in the USA19. Unlike organisms such as Salmonella, C. jejuni is not well known to the general public, in part because the organism was not identified as a human pathogen until the 1970s, when the culturing techniques enabling isolation were developed16.

The Guillain-Barré syndrome (GBS) is an acute, progressive neuropathy which is characterised by paralysis, pain, muscular weakness and distal sensory loss. In severe cases, respiration, swallowing, eye motion and autonomic functions may be affected. Patients are often bed-ridden because of paralysis and mechanical pulmonary support may be required; most patients are hospitalised17. The disease progresses rapidly, sometimes within the course of a single day, although symptoms sometimes take several weeks to develop. Most patients experience the worst symptoms within a month of disease onset and then recover slowly. The rapidity of disease onset, the severity of the symptoms and the persistence of these symptoms make GBS a particularly devastating illness. Case-fatality rates reported in the literature range from 2% to 8%3,11. Since the decline in polio following widespread public vaccination campaigns, GBS is the leading cause of acute flaccid paralysis throughout the world11. The syndrome can probably arise from a number of viral and bacterial infections, as well as administration of certain drugs and vaccinations14. C. jejuni is recognised as the most common preceding infection11.

Epidemiological studies have highlighted the relationship between GBS and disease resulting from preceding C. jejuni infection. A case-control study of 103 patients with GBS or Miller-Fisher syndrome (a variant of GBS) presented in England and Wales between 1992 and 1994 showed that 26% had preceding C. jejuni infection12. The study found that preceding infection with C. jejuni is associated with neurological degeneration, slow recovery and severe residual disability compared to GBS patients without preceding infection. Prior C. jejuni infection was significantly associated with poor outcome, even after correcting for other factors indicating poor prognosis. Another recent study conducted in the United Kingdom of 79 patients with GBS showed that one year after the onset of disease, 8% of the patients had died, 4% were still bed-ridden and 9% were still unable to walk without assistance11.

The medical costs of GBS associated with C. jejuni infection have been investigated more fully than other long-term sequelae of foodbome diseases. A recent report estimates that of the 2,600 to 9,500 new cases of GBS which occur annually in the USA, between 525 and 3,800 are triggered by infection with C. jejuni 3. The annual costs of C. jejuni-associated GBS are estimated at US$0.2 to US$1.8 x 109 ($200 million to $1.8 billion) in the USA. By comparison, the annual economic impact of acute campylobacteriosis was estimated at US$1.3 to US$6.2 x 109 ($1.3 billion to $6.2 billion) which means that long-term sequelae to C. jejuni are of the same magnitude as the costs of acute illness, despite the fact that the long-term complications are at least 100 times less common.

Crohn's disease in humans and Johne's disease in cattle

Although there is strong evidence showing causal links between foodbome pathogens and the conditions discussed above, the link between Crohn's disease and Mycobacterium paratuberculosis is less strong. The cause of Crohn's disease remains unknown4,21. Researchers are investigating several possible agents and conditions but there have been no deflnitive results. If M. paratuberculosis were proved to be the cause of Crohn's disease, foodborne exposure would probably be the major source of human contamination.

Mycobacterium paratuberculosis is the causative agent for Joline's disease in cattle, sheep and.goats. Johne's disease is a chronic granulomatous intestinal infection of the ileocaecal region of the intestine9. Animals are often infected at a young age through exposure to faeces from cattle shedding the organism. The clinical signs of johne's disease - persistent diarrhoea and weight loss - may not be revealed until two to five years after infection. Johne's disease is reported in every country in the world with animal agriculture and adequate laboratory facilities for diagnosis. In the USA, 5%-10% of dairy cattle are infected with M. paratuberculosis, and up to one third of herds in Wisconsin showed serological evidence of infection in 19946.

Crohn's disease in humans is displayed as a chronic granulomatous enteritis very similar to Johne's disease in cattle. In the 1980s, researchers reported an occasional isolation of M. paratuberculosis from patients with Crohn's disease4,21. Standard culture techniques for mycobacteria proved inefficient in isolating M. paratuberculosis because the bacterium often occurred as cell-wall deficient (called spheroblasts). These spheroblasts fail to survive standard culturing techniques. There is also a possibility that the spheroblast form of M. paratuberculosis would not be noticed in tissue samples used for histopathology. Other methods of detection, such as polymerase chain reaction and genetic probes, are currently used to detect M. paratuberculosis. Many researchers have performed case-control studies to compare the prevalence of M. paratuberculosis in Crohn's disease patients and controls. These studies have shown prevalence rates ranging from 40% to over 75% in the Crohn's disease patients compared to 0% to 25% in the controls. However, other researchers found no significant difference in the prevalence6.

While the research does not prove a causal association between M. paratuberculosis and Crohn's disease, there appears to be substantial proof to show an association, at least for a substantial proportion of the Crohn's disease patients. If a causal link was proved, public health officials would have to re-evaluate current management of Johne's disease, particularly in dairy cattle.

Cattle infected with Johne's disease can shed the bacterium in faeces and milk, thus M. paratuberculosis is often present in raw milk, either directly or indirectly through faecal contamination20. Recent research has suggested that M. paratuberculosis is more closely related to the M. avium complex than to other mycobacteria. This is significant because both M. paratuberculosis and M. avium are more resistant to pasteurisation time and temperature criteria than other milk-borne pathogens5. Current pasteurisation methods may not kill all M. paratuberculosis organisms present in milk, which is of particular importance when considering that approximately one third of the cheese produced in the USA is derived from unpasteurised milk6.

When Johne's disease is diagnosed in a cow on a dairy farm, the standard recommendation is to send the animal to slaughter. In the late stages of the disease, M. paratuberculosis may be spread systemically throughout the animal7. Most of these cull dairy cows pass ante-mortem inspection and enter the slaughter system for production of ground beef. Whether by systemic infection or contamination from faeces, these cattle pose a great risk for contamination of the final product (ground beef) with M. paratuberculosis 6.

Research is ongoing to determine whether M. paratuberculosis in the food supply poses a health risk to humans, either through Crohn's disease or some other manifestation. If a link is ever proved, current systems for producing milk and meat will have to be re-evaluated to determine whether more effective mitigation measures are needed to reduce exposure to this bacterium.


In addition to the well-known symptoms and associated impact of the acute form of foodbome diseases, a number of bacterial, viral and parasitic pathogens can cause long-term sequelae which are perhaps more economically significant than the effects 6f acute disease. The long-term sequelae impose significant costs on individuals, families and communities. The sheer magnitude of the impact associated with these long-term sequelae invites additional analysis and research to determine whether cost-effective mitigation strategies can be developed to reduce the occurrence of these diseases.


1Archer D.L. & Kvenbergj.E. (1985). - Incidence and cost of food-borne diarrhdeal disease in the United States. J. Food Protec., 48, 887-894.
2.Archer D.L. & Young F.E. (1988). - Contemporary issues: diseases with a food vector. Clin. Microbiol. Rev., 1, 377-398.
3.Buzby J.C., Roberts T. & Allos B.M. (1997). - Estimated annual costs of Campylobacter-associated Guillain-Barré syndrome. Agricultural Economic Report No.756. Economic Research Service, United States Department of Agriculture, Washington, DC, July, 29 pp.
4.Chiodini RJ. (1989). - Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin. Microbiol. Rev., 2, 90-117.
5.Chiodini RJ. & Hermon-Taylor J. (1993). - The thermal resistance of Mycobacterium paratuberculosis in raw milk under conditions simulating pasteurization. J. vet. Diagn. Invest., 5 (4), 629-631.
6.Collins M.T. (1996). - Crohn's disease and Johne's disease: are they the same? Is Crohn's an infectious disease? Monograph, School of Veterinary Medicine, University of Wisconsin, 9 pp.
7.Chiodini RJ., Collins M.T. & Bassey E.O.E. (eds) (1995). -Proceedings of the Fourth International Colloquium on Paratuberculosis, July 1994, Cambridge (England). International Association for Paratuberculosis, Madison, Wisconsin, 403 pp.
8.Council for Agriculture, Science and Technology (CAST) (1994). - Foodbome pathogens: risks and consequences. Task Force Report No.122. CAST, Ames, 87 pp.
9Larsen A.B. (1981). - Johne's disease (paratuberculosis). In Current veterinary therapy, food animal practice (J.L. Howard, ed.). W.B. Saunders & Co., Philadelphia, 746-748.
10.Locht H.E., Kihlstrom E. & Lindstrom F.D. (1993). -Reactive arthritis after Salmonella among medical doctors -study of an outbreak.J. Rheum., 20, 845-848.
11National Institutes of Health (NIH) (1996). - Proceedings of the Conference on development of Guillain-Barré syndrome following Campylobacter infection, 26-27 August, Bethesda, Maryland. Office of Communications, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, 4pp.
12.Rees J.H., Soudain S.E., Gregson N.A. & Hughes R.A.C. (1995). - Campylobacter jejuni infection and Guillain-Barré syndrome. N. Eng.]. Med., 333, 1374-1379.
13.Roberts T. & Frenckel J.K. (1990). - Estimating income losses and other preventable costs caused by toxoplasmosis in people in the United States. J. Am. vet. med. Assoc., 196, 249-256.
14.Ropper A.H. (1992). - The Guillain-Barré syndrome. N. Eng. J Med., 326, 1130-1136.
15.Smith J.L. (1994). - Arthritis and foodborne bacteria.J. Food Protec., 57 (10), 935-941.
16.Smith J.L. (1995). - Arthritis, Guillain-Barre syndrome, and other sequelae of Campylobacter jejuni enteritis. J. Food Protec.,58 (10), 1153-1170.
17.Smith J.L. (1996). - Determinant that may be involved in virulence and disease in Campylobacter jejuni. J. Food Safety,16, 105-139.
18.Smith J.L., Palumbo S.A. & Walls I. (1993). - Relationship between foodbome bacterial pathogens and the reactive arthritides.J. Food Safety, 13, 209-236.
19.Tauxe R.V., Hargrett-Bean N., Patton C.M. & Wachsmuth I.K. (1988). - Campylobacter isolates in the United States, 1982-1986. Morbidity and Mortality Weekly Report, 37, No. SS-2, 1-13.
20.Taylor T.K., Wilks C.R. & McQueen D.S. (1981). - Isolation of M. paratuberculosis from milk of a cow with Johne's disease. Vet. Rec., 109, 532-533.
21.Thompson D.E. (1994). - The role of mycobacteria in Crohn's disease.J. med. Microbiol., 41, 74-94.